Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220013463 220007870 1.4 57.1 Adjuvant (A) 2013-03-19 2013-04-22 Hydroxycarbamide N N 220030214 HYDROXYCARBAMIDE
220013464 220017815 1.81 0 Disease modification (D) 2013-08-03 2013-12-06 Hydroxycarbamide N N 220030215 HYDROXYCARBAMIDE
220013465 220007871 1.82 34.2 Curative (C) 2013-08-04 2013-09-12 AML Interim Guidelines FLA -Ida 02 N 220030216 NOT MATCHED
220013466 220014324 1.8 86.5 Palliative (P) null 2015-05-30 Cytarabine Low Dose N N 220030217 CYTARABINE
220013469 220007873 1.04 null Palliative (P) 2016-10-31 2017-03-26 Hydroxycarbamide N N 220030225 HYDROXYCARBAMIDE
220013470 220007877 0 48 Palliative (P) 2017-08-28 2017-08-28 Hydroxycarbamide N N 220030228 HYDROXYCARBAMIDE
220013471 220007877 1.86 null Curative (C) 2016-12-17 2016-12-21 Cytarabine low (10to20mg/m2) IV/SC N N 220030228 CYTARABINE
220013472 220014329 null 65.1 Curative (C) 2017-03-02 2017-03-02 AML Interim Guidelines FLA N N 220030235 NOT MATCHED
220013473 220007882 1.73 null Disease modification (D) null 2017-08-30 Hydroxycarbamide N N 220030236 HYDROXYCARBAMIDE
220013474 220007883 1.83 63.3 Palliative (P) 2016-11-27 2016-12-12 CYTARABINE null null 220030238 CYTARABINE
220013475 220007883 1.77 82 Curative (C) 2016-04-24 2016-04-24 AML MyeChild 01 FLA-Idarubicin 2 N 220030238 NOT MATCHED
220013476 220007883 1.63 null Curative (C) 2013-04-04 2013-04-18 CYTARABINE 99 N 220030238 CYTARABINE
220013477 220007883 1.7 85.6 Neo-adjuvant (N) 2015-01-15 2015-01-15 Hydroxycarbamide 02 N 220030238 HYDROXYCARBAMIDE
220013478 220007886 1.81 13.6 Disease modification (D) 2014-06-16 2014-06-16 null N N 220030255 NOT MATCHED
220013479 220007887 1.86 0 Palliative (P) 2016-07-20 2016-07-20 Hydroxycarbamide N N 220030261 HYDROXYCARBAMIDE
220013483 220007891 0 87.1 Not known (9) null 2014-06-14 Cytarabine Low Dose 02 N 220030274 CYTARABINE
220013484 220014333 1.44 96.7 Disease modification (D) 2017-04-08 2017-04-19 CYTARABINE null null 220030275 CYTARABINE
220013485 220007894 null 35 null 2017-12-14 2017-12-14 ATG + Cyclophosphamide TBI Allo 01 N 220030276 NOT MATCHED
220013486 220007896 null 101 Palliative (P) null 2014-01-21 Hydroxycarbamide null null 220030281 HYDROXYCARBAMIDE
220013488 220007899 null 0 Palliative (P) 2013-07-11 2013-07-25 CYTARABINE N N 220030289 CYTARABINE
220013489 220007900 1.78 66.5 Palliative (P) 2014-07-08 2014-07-27 AML Interim Guidelines FLA -Ida 02 N 220030292 NOT MATCHED
220013490 220007901 null 62.2 null 2016-01-29 2016-02-08 AML Interim Guidelines FLA null null 220030292 NOT MATCHED
220013491 220014336 null 38.4 Palliative (P) 2014-08-18 2014-08-18 AML Relapsed High Dose Cytarabine N N 220030293 NOT MATCHED
220013492 220014336 null 6.9 Palliative (P) 2018-01-19 2018-01-28 AML MyeChild 01 FLA-Idarubicin N N 220030293 NOT MATCHED
220013493 220007904 null null Palliative (P) 2017-02-26 2017-03-02 Cytarabine Low Dose 2 N 220030299 CYTARABINE
220013494 220007907 null 22.9 Curative (C) 2014-04-16 2014-04-30 AML MyeChild 01 IT Cyt 02 N 220030302 NOT MATCHED
220013495 220007909 null 54 Disease modification (D) 2016-11-21 2016-11-21 Hydroxycarbamide N N 220030302 HYDROXYCARBAMIDE
220013496 220007910 1.55 51.2 Curative (C) 2016-12-21 2016-12-21 Hydroxycarbamide 99 N 220030307 HYDROXYCARBAMIDE
220013497 220014340 1.6 null Curative (C) 2016-07-09 2016-07-30 Cytarabine Low Dose 1 N 220030309 CYTARABINE
220013498 220007911 null 9.7 Palliative (P) 2016-11-24 2016-12-09 null N N 220030310 NOT MATCHED
220013499 220007912 0 59.6 Disease modification (D) 2017-03-29 2017-03-29 CYTARABINE N N 220030311 CYTARABINE
220013501 220007913 null 0 Adjuvant (A) 2016-03-07 2017-02-15 Hydroxycarbamide 02 N 220030313 HYDROXYCARBAMIDE
220013502 220007913 1.6 10 Curative (C) null 2014-08-04 ATG + Cyclophosphamide TBI Allo 99 null 220030313 NOT MATCHED
220013503 220007914 1.69 111.8 Not known (9) 2014-12-07 2014-12-19 Cytarabine low (10to20mg/m2) IV/SC Y N 220030316 CYTARABINE
220013504 220007917 1.56 null null 2017-07-01 2017-07-02 Hydroxycarbamide null N 220030318 HYDROXYCARBAMIDE
220013505 220007918 null 5.8 Palliative (P) null 2014-12-21 AML MyeChild 01 IT Cyt 02 N 220030319 NOT MATCHED
220013506 220007919 1.77 87.7 Curative (C) 2017-05-12 2017-05-16 Cytarabine Low Dose N N 220030320 CYTARABINE
220013507 220007920 1.56 16.6 Curative (C) 2017-06-14 2017-06-14 AML MyeChild 01 A Mitozantrone/Cytarabine null null 220030322 NOT MATCHED
220013508 220007921 null 38.4 Adjuvant (A) 2014-01-25 2014-01-26 null null null 220030324 NOT MATCHED
220013509 220007922 1.75 76.5 Curative (C) 2017-07-10 2017-07-21 ANTITHYMOCYTE IMMUNOGLOBULIN (RABBIT) + BUSULFAN + CYCLOPHOSPHAMIDE 2 N 220030325 NOT MATCHED
220013510 220007923 null null Palliative (P) null 2016-01-25 Cytarabine Low Dose N null 220030329 CYTARABINE
220013511 220014346 null 77.4 Curative (C) 2015-02-14 2015-05-16 FBC Conditionining null N 220030332 NOT MATCHED
220013512 220014346 null 96.7 Curative (C) null 2018-03-14 Cytarabine Low Dose N N 220030332 CYTARABINE
220013513 220019778 0 69.5 Adjuvant (A) 2015-01-16 2015-01-16 Cytarabine Low Dose N N 220030337 CYTARABINE
220013514 220007925 1.77 77.4 Curative (C) 2013-08-10 2013-09-20 null N N 220030339 NOT MATCHED
220013515 220017824 1.68 11.2 Curative (C) 2017-01-06 2017-01-26 AML Downs haM N N 220030339 NOT MATCHED
220013516 220017824 1.56 59.4 Disease modification (D) 2015-10-23 2015-11-08 Hydroxycarbamide N N 220030339 HYDROXYCARBAMIDE
220013517 220007927 0 null Palliative (P) null 2014-11-23 Hydroxycarbamide N N 220030348 HYDROXYCARBAMIDE
220013518 220007927 1.73 18.6 Curative (C) 2014-09-06 2014-11-14 Quizartinib (AC220) N null 220030348 NOT MATCHED
220013519 220019780 null null Curative (C) 2013-06-17 2013-07-04 ALEMTUZUMAB + FLUDARABINE + MELPHALAN N null 220030353 ALEMTUZUMAB + FLUDARABINE + MELPHALAN